Biopharmaceutical Outsourcing Boosting the Antibody Contract Manufacturing Market Growth
The rapid expansion of biologics and targeted therapies has significantly transformed the global pharmaceutical landscape. Increasing reliance on outsourced production models has accelerated growth across antibody contract manufacturing, monoclonal antibody manufacturing, and the biologics contract manufacturing organization (CMO/CDMO) sector. These developments are collectively driving the...
0 Σχόλια 0 Μοιράστηκε 5 Views 0 Προεπισκόπηση